XTX Topco’s Cardio Diagnostics CDIO Stock Holding History

XTX Topco’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,912	Closed	-$18.9K	–	2426
2025 Q1	$18.9K	Buy	1,912 +1,149	+151%	+$17.9K	﹤0.01%	2148
2024 Q4	$21K	Buy	+763	New	+$10.6K	﹤0.01%	2030

Other funds holding CDIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XTX Topco's CDIO Position: Q2 2025 in Review

XTX Topco sold out of Cardio Diagnostics (CDIO) in Q2 2025, closing a stake of 1,912 shares — an estimated $18.9K sold.

XTX Topco first reported a position in CDIO in Q4 2024 and held it in 2 quarters. The position peaked at $21K in Q4 2024. 16 funds tracked by Wall St. Rank hold CDIO as of Q2 2025.

XTX Topco reported no remaining Cardio Diagnostics position as of Q2 2025 after selling out during the quarter.
XTX Topco sold 1,912 Cardio Diagnostics shares in Q2 2025, an estimated $18.9K.
XTX Topco first reported a position in Cardio Diagnostics in Q4 2024 and held it in 2 quarters.
XTX Topco's Cardio Diagnostics position peaked at $21K in Q4 2024.
16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.